Skip to content

PLASMA PROTEIN THERAPEUTICS ASSOCIATION EUROPE

Active
Int'l non-profit associationfounded 199431 yrs activeBrand Whitlocklaan 114, 1200 Sint-Lambrechts-Woluwe, BelgiumKBO/BCE: BE 0453.837.462
Summary

PLASMA PROTEIN THERAPEUTICS ASSOCIATION EUROPE has been active since 1994 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €865k and a net result of €95k. Equity is growing by ~19.8% per year across the filed fiscal years. Its solvency ranks better than 42% of 2331 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).

Checked score

Score 2025
82 / 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability51▲+18
Solvency75▼-2
Growth51▼-1
Track record100
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €70k at 30 days acceptable
Liquidity ample (current ratio 3.48 against 2.89 in 2024; short-term debt: 28.2% and cash: 59.7% of total assets), and 49.6% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 31 years 0 40 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
50.4%
Return on assets
5.5%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 11-07-2026, 20 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
20 d early
2024
19 d early
2023
18 d late
2022
27 d early
2021
9 d late
2020
20 d late
2019
84 d late
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, abbreviated schema

Turnover
€3.39M▼ 1.5%
2024 · €3.44M
2018: €2.56M 2019: €2.43M 2020: €1.83M 2021: €3.18M 2022: €3.90M 2023: €5.10M 2024: €3.44M
2018 → 2025
EBIT margin
2.8%▲ 3.5pp
2024 · -0.7%
2018: 6.7% 2019: 5.5% 2020: -26.7% 2021: 17.3% 2022: -3.9% 2023: 8.9% 2024: -0.7%
2018 → 2025
Net result
€95k
2024 · €-25k
2018: €114k 2019: €132k 2020: €-488k 2021: €551k 2022: €-157k 2023: €455k 2024: €-25k
2018 → 2025
Working capital
€1.20M▲ 26.5%
2024 · €950k
2018: €460k 2019: €777k 2020: €205k 2021: €757k 2022: €616k 2023: €958k 2024: €950k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Turnover€3.18M-€3.90M▲ 22.6%€5.10M▲ 30.8%€3.44M▼ 32.6%€3.39M▼ 1.5%
Equity€494k-€338k▼ 31.7%€795k▲ 135%€770k▼ 3.1%€865k▲ 12.3%
Operating result€551k-€-153k€456k€-24k€95k
Net result€551k-€-157k€455k€-25k€95k
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€-200k€0€200k€400k€600kOperating result 2021: €551k€551kNet result 2021: €551k€551kOperating result 2022: €-153k€-153kNet result 2022: €-157k€-157kOperating result 2023: €456k€456kNet result 2023: €455k€455kOperating result 2024: €-24k€-24kNet result 2024: €-25k€-25kOperating result 2025: €95k€95kNet result 2025: €95k€95k20212022202320242025€-200k€0€200k€400kOperating result 2023: €456k€456kNet result 2023: €455k€455kOperating result 2024: €-24k€-24kNet result 2024: €-25k€-25kOperating result 2025: €95k€95kNet result 2025: €95k€95k202320242025
The operating result returns to profit in 2025: €95k after a loss of €24k in 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.72M
Fixed assets €32k ▲ 1.7%
Current assets €1.69M ▲ 16.0%
Equity and liabilities €1.72M
Equity €865k ▲ 12.3%
Debt €852k ▲ 19.4%
Debt's share of the balance-sheet total rises from 48.1% to 49.6%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
Current ratio
3.48
2024 · 2.89
Debt to equity
0.98
2024 · 0.93
ROE
11.0%
2024 · -3.2%
ROA
5.5%
2024 · -1.7%
Debt ≤ 1 year
€484k
2024 · €503k
Staff costs
€1.52M
2024 · €1.90M
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 42 lines
Balance sheet Code20242025
Assets
Total assets20/58€1.48M€1.72M
Fixed assets21/28€32k€32k
Financial fixed assets28€32k€32k
Other financial fixed assets284/8€32k€32k
Amounts receivable and cash guarantees285/8€32k€32k
Current assets29/58€1.45M€1.69M
Amounts receivable within one year40/41€361k€594k
Trade receivables40€175k€300k
Other amounts receivable41€186k€293k
Cash at bank and in hand54/58€1.02M€1.02M
Deferred charges and accrued income490/1€74k€67k
Equity and liabilities
Total equity and liabilities10/49€1.48M€1.72M
Equity10/15€770k€865k
Profit (loss) carried forward14€770k€865k
Amounts payable17/49€714k€852k
Amounts payable within one year42/48€503k€484k
Trade debts44€71k€38k
Suppliers440/4€71k€38k
Taxes, remuneration and social security45€431k€444k
Taxes450/3€56k€54k
Remuneration and social security454/9€375k€390k
Accrued charges and deferred income492/3€211k€368k
Income statement Code20242025
Operating income70/76A€3.44M€3.39M
Turnover70€3.44M€3.39M
Operating charges60/66A€3.46M€3.29M
Services and other goods61€1.54M€1.67M
Remuneration, social security and pensions62€1.90M€1.52M
Other operating charges640/8€189€231
Non-recurring operating charges66A€26k€100k
Operating profit (loss)9901€-24k€95k
Financial income75/76B-€553
Recurring financial income75-€553
Income from current assets751-€553
Financial charges65/66B€576€767
Recurring financial charges65€576€767
Other financial charges652/9€576€767
Profit (loss) for the period before taxes9903€-25k€95k
Profit (loss) for the period9904€-25k€95k
Profit (loss) for the period to be appropriated9905€-25k€95k
Appropriation of the result
Profit (loss) to be appropriated9906€770k€865k
Profit (loss) brought forward from the previous period14P€795k€770k
Social balance
Average headcount (FTE)908710.58.0

The notes to these accounts (15 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
15-09
State Gazette act Resignation: Giles Platford (director)
Appointments: Ramy Riad Ahmed Ibrahim (director) and David lan Bell (chair) · Withdrawal: Deborah Hibbett (membre du conseil régional européen) · Admission: Luana Elena Banu (membre du conseil régional européen)8 facts ▸
  • General meeting, 27-04-2026
  • Director resignation, Giles Platford (director)
  • Director appointment, Ramy Riad Ahmed Ibrahim (director)
  • Member resignation, Deborah Hibbett (membre du conseil régional européen)
  • Member admission, Luana Elena Banu (membre du conseil régional européen)
  • Board meeting, 27-04-2026
  • Director resignation, Giles Platford (chair)
  • Director appointment, David lan Bell (chair)
11-07
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial Back to profitnet €95k
Net result €95k after one loss-making year.
10-10
State Gazette act Resignations: Ferdinando Borgese, Santiago Gonzalez Orti and Deborah Hibbett
Appointments: Giles Platford, David Bell and Paolo Marcucci · Admissions: Ferdinando Borgese, Santiago Gonzalez Orti and Deborah Hibbett · Statutes amendment21 facts ▸
  • General meeting, 11-06-2025
  • Board meeting, 12-06-2025
  • Statutes amendment
  • Director resignation, Ferdinando Borgese (director)
  • Director resignation, Santiago Gonzalez Orti (director)
  • Director resignation, Deborah Hibbett (director)
  • Director appointment, Giles Platford (director)
  • Director appointment, David Bell (director)
  • Director appointment, Paolo Marcucci (director)
  • Mandate compensation, Giles Platford
  • Mandate compensation, David Bell
  • Mandate compensation, Paolo Marcucci
  • +9 further facts in this act
12-07
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
25-04
State Gazette act Resignation: Richard Corliss (director)
Appointment: Deborah Hibbett (director) · Director discharge · Mandate compensation5 facts ▸
  • General meeting, 04-03-2025
  • Director resignation, Richard Corliss (director)
  • Director discharge, Richard Corliss
  • Director appointment, Deborah Hibbett (director)
  • Mandate compensation, Deborah Hibbett
2024
25-11
State Gazette act Resignation: Maarten Van Baelen (day-to-day manager)
Appointment: Anita Brikmanis Spear (day-to-day manager) · Mandate compensation · Power of attorney5 facts ▸
  • Director resignation, Maarten Van Baelen (day-to-day manager)
  • Director appointment, Anita Brikmanis Spear (day-to-day manager)
  • Mandate compensation, Anita Brikmanis Spear
  • Power of attorney, Catherine Izzi
  • Mandate compensation, Catherine Izzi
09-09
State Gazette act Resignation: Timothy Leijten (director)
Reappointments: Santiago Gonzalez Orti, Ferdinando Borgese and Richard Corliss5 facts ▸
  • General meeting, 28-06-2024
  • Director resignation, Timothy Leijten (director)
  • Director reappointment, Santiago Gonzalez Orti (director)
  • Director reappointment, Ferdinando Borgese (director)
  • Director reappointment, Richard Corliss (director)
18-08
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema · 18 days late
2023
31-12
Financial Back to profitnet €455k
Net result €455k after one loss-making year.
31-12
Financial Equity above €500kEq €795k ▲135%
Equity rises from €338k to €795k.
10-08
State Gazette act Resignation: Ainhoa Mendizabal (director)
Appointment: Santiago Gonzalez Orti (director) · Mandate compensation4 facts ▸
  • General meeting, 21-06-2023
  • Director resignation, Ainhoa Mendizabal (director)
  • Director appointment, Santiago Gonzalez Orti (director)
  • Mandate compensation, Santiago Gonzalez Orti
Show earlier events
04-07
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
03-02
State Gazette act Resignations: Olivier Schmitt, Michael Mensa and 2 others
Appointments: Ferdinando Borgese (director) and Richard Corliss (director) · Statutes amendment · Director discharge15 facts ▸
  • General meeting, 19-12-2022
  • Statutes amendment, 18
  • Director resignation, Olivier Schmitt (director)
  • Director resignation, Michael Mensa (director)
  • Director resignation, Robertus De With (director)
  • Director resignation, Roberto Tana (director)
  • Director discharge, Olivier Schmitt (director)
  • Director discharge, Michael Mensa (director)
  • Director discharge, Robertus De With (director)
  • Director discharge, Roberto Tana (director)
  • Director appointment, Ferdinando Borgese (director)
  • Director appointment, Richard Corliss (director)
  • +3 further facts in this act
2022
19-09
State Gazette act Resignations: Thierry Heinrich, Enc Thomas and 2 others
Appointments: Ainhoa Mendizabal, Timothy Leijten and Roberto Tana · Reappointments: Robertus de With (director) and Michael Mensa (director) · Director discharge21 facts ▸
  • General meeting, 15-06-2022
  • Board meeting, 15-06-2022
  • Director resignation, Thierry Heinrich (director)
  • Director discharge, Thierry Heinrich
  • Director resignation, Enc Thomas (director)
  • Director discharge, Enc Thomas
  • Director resignation, Ruud Zoethout (director)
  • Director discharge, Ruud Zoethout
  • Director resignation, Olivier Schmitt (director)
  • Director resignation, Olivier Schmitt (chair)
  • Director appointment, Ainhoa Mendizabal (director)
  • Director appointment, Timothy Leijten (director)
  • +9 further facts in this act
09-08
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema · 9 days late
2021
31-12
Financial Back to profitnet €551k
Net result €551k after one loss-making year.
31-12
Financial Equity above €200kEq €494k
Equity rises from €-56k to €494k.
30-11
State Gazette act Reappointments: Roberto Tana, Thierry Heinrich and 2 others
Appointment: Rudy Zoethout (director) · Resignation: Charles Waller (directeur exécutif) · Admission: SPP (member)13 facts ▸
  • General meeting, 22-06-2021
  • Board meeting, 22-06-2021
  • Director reappointment, Roberto Tana (director)
  • Director reappointment, Thierry Heinrich (director)
  • Director reappointment, Oliver Schmitt (director)
  • Director reappointment, Eric Thomas (director)
  • Mandate compensation, Roberto Tana
  • Mandate compensation, Thierry Heinrich
  • Mandate compensation, Oliver Schmitt
  • Mandate compensation, Eric Thomas
  • Director appointment, Rudy Zoethout (director)
  • Director resignation, Charles Waller (directeur exécutif)
  • +1 further facts in this act
20-08
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema · 20 days late
2020
31-12
Financial Weakest financial yearnet €-488k ▼468%
Net result drops to €-488k, the lowest in the series; recovery starts the following year.
04-12
State Gazette act Resignations: Paul Böckmann (director) and Katarzyna Witkos (director)
Appointments: Michael Mensa (director) and Robertus de With (director) · Director discharge7 facts ▸
  • General meeting, 04-09-2020
  • Director resignation, Paul Böckmann (director)
  • Director resignation, Katarzyna Witkos (director)
  • Director discharge, Paul Böckmann
  • Director discharge, Katarzyna Witkos
  • Director appointment, Michael Mensa (director)
  • Director appointment, Robertus de With (director)
17-11
State Gazette act Statutes amendment
2 facts ▸
  • General meeting, 12/10/2020
  • Statutes amendment
23-10
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema · 84 days late
2019
04-12
State Gazette act Appointments: Roberto Tana, Maarten Van Baelen and 2 others
Reappointments: Thierry Heinrich, Olivier Schmitt and 3 others · Mandate compensation · Power of attorney18 facts ▸
  • General meeting, 02-09-2019
  • Director appointment, Roberto Tana (director)
  • Mandate compensation, Roberto Tana
  • Director reappointment, Thierry Heinrich (director)
  • Mandate compensation, Thierry Heinrich
  • Director reappointment, Olivier Schmitt (director)
  • Mandate compensation, Olivier Schmitt
  • Director reappointment, Eric Thomas (director)
  • Mandate compensation, Eric Thomas
  • Director reappointment, Kasha Witkos (director)
  • Mandate compensation, Kasha Witkos
  • Director reappointment, Paul Bockmann (director)
  • +6 further facts in this act
08-10
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema · 69 days late
2018
29-10
State Gazette act Resignation: Bruno Santoni (directeur exécutif)
2 facts ▸
  • Board meeting, 18-09-2018
  • Director resignation, Bruno Santoni (directeur exécutif)
09-10
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema · 70 days late
2017
04-09
State Gazette act Resignations: Joachim Herborg, Ferdinando Borgese and Robert de With
Reappointments: Thierry Heinrich (director) and Oliver Schmitt (director) · Appointments: Eric Thomas, Silvio Audisio and 2 others · Mandate compensation16 facts ▸
  • General meeting, 06-04-2017
  • Director resignation, Joachim Herborg (director)
  • Director resignation, Ferdinando Borgese (director)
  • Director resignation, Robert de With (director)
  • Director reappointment, Thierry Heinrich (director)
  • Director reappointment, Oliver Schmitt (director)
  • Director appointment, Eric Thomas (director)
  • Director appointment, Silvio Audisio (director)
  • Director appointment, Kasha Witkos (director)
  • Director appointment, Paul Böckmann (director)
  • Mandate compensation, Thierry Heinrich
  • Mandate compensation, Oliver Schmitt
  • +4 further facts in this act
08-08
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema · 8 days late
2016
03-05
State Gazette act Resignation: Pawel Jozef Zelewski (director)
Appointment: Robert de With (director) · Approval · Director discharge7 facts ▸
  • General meeting, 24-03-2016
  • Approval, comptes annuels, 2015
  • Director discharge, Plasma Protein Therapeutics Association Europe
  • Director resignation, Pawel Jozef Zelewski (director)
  • Director appointment, Robert de With (director)
  • Mandate compensation, Robert de With
  • Approval, budget, 2016
2015
26-08
State Gazette act Reappointments: Joachim Herborg, Thiery Heinrich and 3 others
Approval · Director discharge · Mandate compensation9 facts ▸
  • General meeting, 03-06-2015
  • Approval, comptes annuels, 2014
  • Director discharge, Plasma Protein Therapeutics Association Europe
  • Director reappointment, Joachim Herborg (director)
  • Director reappointment, Thiery Heinrich (director)
  • Director reappointment, Oliver Schmitt (director)
  • Director reappointment, Pawel Jozef Zelewski (director)
  • Director reappointment, Ferdinando Borgese (director)
  • Mandate compensation, Plasma Protein Therapeutics Association Europe
02-02
State Gazette act Resignations: James Fischer (director) and Giovanni Rinaldi (director)
Appointments: Pawel Jozef Zelewski (director) and Ferdinando Borgese (director)5 facts ▸
  • Board meeting, 26-11-2014
  • Director resignation, James Fischer (director)
  • Director resignation, Giovanni Rinaldi (director)
  • Director appointment, Pawel Jozef Zelewski (director)
  • Director appointment, Ferdinando Borgese (director)
2014
06-05
State Gazette act Appointment: Bruno Santoni (directeur exécutif)
Power of attorney4 facts ▸
  • Board meeting, 25-02-2014
  • Director appointment, Bruno Santoni (directeur exécutif)
  • Power of attorney, Bruno Santoni
  • Power of attorney, Bruno Santoni
2013
05-07
State Gazette act Reappointments: James Fischer, Thierry Heinrich and 3 others
6 facts ▸
  • General meeting, 22-05-2013
  • Director reappointment, James Fischer (director)
  • Director reappointment, Thierry Heinrich (director)
  • Director reappointment, Joachim Herborg (director)
  • Director reappointment, Giovanni Rinaldi (director)
  • Director reappointment, Oliver Schmitt (director)
2012
12-07
State Gazette act Resignation: Eva Bastida (director)
2 facts ▸
  • General meeting, 24-05-2012
  • Director resignation, Eva Bastida (director)
2011
23-08
State Gazette act Reappointments: Eva Bastida, Giovanni Rinaldi and 2 others
Appointments: James Fischer (director) and Oliver Schmitt (director) · Mandate compensation8 facts ▸
  • General meeting, 23-02-2011
  • Director reappointment, Eva Bastida (director)
  • Director reappointment, Giovanni Rinaldi (director)
  • Director reappointment, Joachim Herborg (director)
  • Director reappointment, Thierry Heinrich (director)
  • Director appointment, James Fischer (director)
  • Director appointment, Oliver Schmitt (director)
  • Mandate compensation, PLASMA PROTEIN THERAPEUTICS ASSOCIATION EUROPE
2008
22-12
State Gazette act Appointments: Docteur Joachim Herborg, Docteur Thierry Heinrich and 3 others
Reappointments: Docteur Giovanni Rinaldi (director) and Monsieur Kim Bjömstrup (director) · Resignations: Docteur Simon Green, Docteur Rainer Pabst and 2 others · Mandate compensation15 facts ▸
  • General meeting, 22-10-2008
  • Director appointment, Docteur Joachim Herborg (director)
  • Director appointment, Docteur Thierry Heinrich (director)
  • Director appointment, Docteur Roland Martin (director)
  • Director appointment, Monsieur Daniel Kenny (director)
  • Director reappointment, Docteur Giovanni Rinaldi (director)
  • Director reappointment, Monsieur Kim Bjömstrup (director)
  • Mandate compensation, PLASMA PROTEIN THERAPEUTICS ASSOCIATION EUROPE
  • Director resignation, Docteur Simon Green (director)
  • Director resignation, Docteur Rainer Pabst (director)
  • Director resignation, Monsieur Klaus Schaefer (director)
  • Director resignation, Monsieur Alton Shader (director)
  • +3 further facts in this act
2006
11-12
State Gazette act Appointments: Docteur Rainer Pabst, Docteur Giovanni Rinaldi and 2 others
Resignations: Monsieur Krister Andersson (director) and Bernhard Schaefer (director) · Mandate compensation13 facts ▸
  • General meeting, 11-10-2006
  • Director appointment, Docteur Rainer Pabst (director)
  • Director appointment, Docteur Giovanni Rinaldi (director)
  • Director appointment, Monsieur Kim Bjómstrup (director)
  • Director appointment, Monsieur Klaus Schaefer (director)
  • Mandate compensation, Docteur Rainer Pabst
  • Mandate compensation, Docteur Giovanni Rinaldi
  • Mandate compensation, Monsieur Kim Bjómstrup
  • Mandate compensation, Monsieur Klaus Schaefer
  • Director resignation, Monsieur Krister Andersson (director)
  • Director resignation, Bernhard Schaefer (director)
  • Board meeting, 11-10-2006
  • +1 further facts in this act
2004
26-07
State Gazette act Resignations: Inger Antonsson, Ian Marschall and Christopher Smith
Appointment: Bernhard Schaefer (director) · Mandate compensation6 facts ▸
  • General meeting, 13-11-2003
  • Director resignation, Inger Antonsson (director)
  • Director resignation, Ian Marschall (director)
  • Director resignation, Christopher Smith (director)
  • Director appointment, Bernhard Schaefer (director)
  • Mandate compensation, Bernhard Schaefer
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
17 directors, no change since 2026
David lan Bell
Chair · since 15-09-2026
Current
Ramy Riad Ahmed Ibrahim
Director · since 15-09-2026
Current
David BELL
Director · since 11-06-2025
Current
Paolo Marcucci
Director · since 11-06-2025
Current
Anita Brikmanis Spear
Day-to-day manager · since 27-08-2024
Current
Rudy Zoethout
Director · since 22-06-2021
Current
11 other directors
Eric Thomas
Director · since 06-04-2017
Current
Oliver Schmitt
Director · since 23-02-2011
Current
Kasha Witkos
Director · since 06-04-2017
Not recently confirmed
Silvio Audisio
Director · since 06-04-2017
Not recently confirmed
Thiery Heinrich
Director · since 03-06-2015
Not recently confirmed
Docteur Giovanni Rinaldi
Director · since 11-10-2006
Not recently confirmed
Docteur Joachim Herborg
Director · since 22-10-2008
Not recently confirmed
Docteur Roland Martin
Director · since 22-10-2008
Not recently confirmed
Docteur Thierry Heinrich
Director · since 22-10-2008
Not recently confirmed
Monsieur Daniel Kenny
Director · since 22-10-2008
Not recently confirmed
Monsieur Kim Bjómstrup
Director · since 11-10-2006
Not recently confirmed
15-09-2026 David lan Bell: Appointed as Chair
15-09-2026 Ramy Riad Ahmed Ibrahim: Appointed as Director
15-09-2026 Giles Platford: Resigned as Chair
15-09-2026 Giles Platford: Resigned as Director
11-06-2025 David BELL: Appointed as Director
Full history in the Timeline (115 changes) →
Location & real-estate footprint
Registered office, Sint-Lambrechts-Woluwe · 1 establishment unit since 2015
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Brand Whitlocklaan 1141200 Sint-Lambrechts-Woluwe
Ground area
891 m²
Building footprint
543 m²
Volume, LiDAR
11,117 m³
Parcel 21673D0145/00G006, Brussels · tallest building 29.4 m, ±8 floors. Linked by address, not a title deed.
1 establishment unit
Brand Whitlocklaan 114, 1200 Sint-Lambrechts-Woluwe
Business consulting
since 20152.237.507.710
1 parcel
Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21673D0145/00G006 Brussels 891 m² 1 · 543 m² 29.4 m · 8 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Articles of association

Purpose
1. de fournir à ses membres l'occasion de dialoguer, de représenter leurs intérêts et de se former, tout en respectant les intérêts de la santé publique, et de s'engager à…
Full purpose

1. de fournir à ses membres l'occasion de dialoguer, de représenter leurs intérêts et de se former, tout en respectant les intérêts de la santé publique, et de s'engager à promouvoir la valeur critique et les contributions apportées par ses membres à la santé publique, à la prévention et au traitement des maladies en Europe ; 2. de s'engager dans la quête d'une coopération ouverte et transparente avec les institutions et autorités européennes concernées, et potentiellement avec les associations sans but lucratif ; 3. de promouvoir l'harmonisation de politiques gouvernementales nationales, européennes, et internationales, en se basant sur des normes et des règlements de fabrication de produits à base de plasma techniquement et scientifiquement sûrs ; 4. d'améliorer tous les aspects de l'industrie européenne de production du plasma, y compris les produits de substitution développés par l'intermédiaire de technologies nouvelles ; 5. de développer et d'encourager des normes de conduites élevées pour l'amélioration de toutes les sociétés commerciales impliquées dans la fabrication de produits à base de plasma ; 6. de stimuler et de respecter les politiques gouvernementales et les politiques concernant les consommateurs qui soutiennent une place de marché ouverte à la concurrence, assurant ainsi aux patients un approvisionnement adéquat et sûr de produits à base de plasma ; 7. d'encourager les mesures politiques et législatives qui combattent la discrimination et soutiennent les nombreux fournisseurs de produits à base plasma ; 8. de stimuler le développement et la mise en pratique de politiques affectant la disponibilité et l'utilisation des produits à base de plasma basées sur des informations médicales et scientifiques et des expériences cliniques.

Other provisions of the articles (1)

Structure & network

Connections & network

1 connected company
Linked via shared directors

Similar companies · same sector, comparable size

Of 10,451 companies in sector 86995 we hold annual accounts for 886. 418 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company data · Crossroads Bank

Identification
Legal formInt'l non-profit association
Founded07-11-1994
Fiscal year end31-12
Abbreviation FR PPTA EUROPE
Activities, NACEBEL 2025
70200Business and other management consultancy
86995Nutrition and dietetics services
Sources
Crossroads Bank for EnterprisesNational Bank · 18 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.